In-Vitro Diagnostics Market 2020: Key companies Profile, their market Share and Growth Insights to 2023

In-Vitro Diagnostics Market Synopsis

The increasing burden of diseases such as CVDs, tuberculosis, cancer, diabetes, etc. is poised to increase the demand for in-vitro diagnostics in the years to come. According to Market Research Future (MRFR)’s analysis, the global in-vitro diagnostics market is anticipated to strike 8.16% CAGR across the forecast period 2018 to 2023. The market’s valuation is projected to reach USD 102,555.24 Mn by 2023.

The market is expected to grow substantially in the developing nations over the next couple of years. However, on the contrary, the lack of favorable reimbursement policies remains an impediment to market growth.

In-Vitro Diagnostics Market Leaders

The key players operating in the global in-vitro diagnostics market and profiled in this MRFR report are Abbott Laboratories, F. Hoffmann-La Roche AG, Sysmex Corporation, Siemens AG, Qiagen N.V, BioMérieux S.A, Bio-Rad Laboratories Inc, Becton Dickinson and Company, Ortho Clinical Diagnostics, DiaSorin S.p.A, Grifols S.A, Danaher Corporation, and Thermo Fisher Scientific.

In-Vitro Diagnostics Market Segmentation:

On the basis of product & services, the global in-vitro diagnostics market has been segmented into reagents & kits, instruments, and data management software.

On the basis of application, the in-vitro diagnostics market has been bifurcated into infectious diseases, and non-infectious diseases.

On the basis of technology, the global in-vitro diagnostics market has been segmented into clinical chemistry, molecular, hematology, immunoassay/immunochemistry, microbiology, and others.

On the basis of end-users, the in-vitro diagnostics market has been segmented into laboratories, academic institutes, hospitals, and others.

In-Vitro Diagnostics Market Regional Analysis:

The global in-vitro diagnostics market, by region, has been segmented into Americas, Europe, the Middle East & Africa (MEA) and Asia Pacific. Americas is expected to hold the maximum share of the market over the next couple of years. The region is sub-segmented into North America and South America. Among these, North America is expected to exhibit a steeper rise in the growth curve in the foreseeable future. The consolidation of developed economies in the region such as the U.S., and Canada is anticipated to have a positive impact on the growth of the in-vitro diagnostics market over the next couple of years. The increasing population of older adults is expected to boost the revenue creation for the market players. In addition, the rising burden of chronic diseases such as cancer, obesity, diabetes, etc. is projected to catalyze the proliferation of the regional market in the years to come. Americas is prognosticated to lead the growth of the global market across the review period.

Europe is the second leading region and is poised to expand at a substantial pace in the forthcoming years. The endeavors directed towards organizing awareness campaigns about point-of-care testing is likely to catapult the in-vitro diagnostics market on upward trajectory over the next couple of years. The increasing healthcare expenditure, especially on early diagnosis, is forecasted to accelerate revenue creation for the players of the in-vitro diagnostics market in the years to come.

Browse More Information: 

Asia Pacific is the fastest growing regional segment and is likely to remain highly lucrative over the next couple of years. The rising patient population in Asia Pacific is expected to have a favorable influence on the future trajectory of the in-vitro diagnostics market over the next couple of years. Also, the rapid developments in the healthcare sector of the region supported by the governments are anticipated to catapult the regional in-vitro diagnostics market on upward trajectory. The fast-developing economies, such as China and India have high birth rates. This, in turn, is expected to catalyze the growth of the in-vitro diagnostics market on an upward trajectory in the forthcoming years. Meanwhile, the MEA is prognosticated to have the least share of the market and is projected to exhibit massive developmental opportunities.

Organ Transplantation Market 2020 Covers Global Industry Share, Size, Future Trends, Demand, Business Insight by 2023

The Organ Transplantation Market will prove to be highly profitable in the coming years, expanding at a CAGR of 9.8% during forecast period (2017-2023), as ascertained by the recent report by Market Research Future (MRFR).

Organ transplantation is the process of replacing the damaged or diseased organ with a health organ. Organs like kidney can be donated by the living donors or even harvested from the organ donors that are brain-dead. Organ dysfunction that have been caused owing to severe injuries, organ failure and/or genetic disorders, cancer leads to the need for organ transplant procedures. Moreover, advances in the technology and development within the medical sector has made it possible for transplantation to take place. Heart, kidney, liver, lungs, and various other organs can be transplanted.

Organ Transplantation Market Key Players

Veloxis Pharmaceuticals A/S (Denmark), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Accord Healthcare GmbH (Spain), Novartis International AG (Switzerland), Terumo Medical Corporation (US), Bio Med Pvt. Ltd. (US), Transplant Biomedical (UK), Astellas Pharma, Inc (Japan), TransMedic, Inc. (US), OrganOX Limited (UK), Sanofi (France), Pfizer, Inc. (US), Preservation Solutions, Inc. (US), GlaxoSmithKline Plc. (UK) are some of the leading companies competing in the global organ transplantation market 

Recent Developments

February 2019 – Latest research done at NIHR Guy’s and St Thomas’ Biomedical Research Centre has led to a method that can predict potential rejection of a kidney transplant before it takes place, which can happen by monitoring the immune system of the patients. The team has deduced that a signature combination of seven immune genes present in the blood samples are able to predict the rejection earlier than the techniques used at present.

Organ Transplantation Market Drivers and Key Barriers

As per the National Kidney Foundation, in 2014, almost 122,737 patients in the U.S. were waiting to receive organs for transplant. Therefore, there is massive demand for advanced transplantation products to be used in treating organ failure. The global organ transplantation market is a highly competitive market, with numerous prominent companies investing in research and development (R&D), in a bid to introduce more innovative as well as efficient methods and devices. These companies are under constant pressure to launch new and cost-effective method in order to a maintain their market position or expand their customer base.

For instance, Novartis International AG, a Swiss multinational company based in Switzerland is one of the most well-known pharmaceutical companies, in addition to being the leading manufacturer of analgesic drugs. In the year 2016, the company acquired Selexys Pharmaceuticals with the motive being market expansion. Since then, the company has launched Zortress, which is the first in more than decade to be approved by FDA that prevents organ rejection in adult liver transplant patients.

The flip side to the market growth is the high cost of treatment, which can have a negative impact on the market in the coming years. Nonetheless, a growing number of organ transplantation surgeries around the world will be the driving force behind the growth of the market in years to come. Additional factors like technological advancement, increasing prevalence of chronic diseases, expanding aging population as well as changing lifestyle are also bound to promote further growth of the market.

Organ Transplantation Market Segmentation

The global organ transplantation market is segmented based on the type of organ, product, type of transplant, treatment and end-user.

The types of organ that can be transplanted are heart, kidney, liver, lungs, and other.

Product-wise, the market has been segmented into organ preservation solutions, transplant diagnostics, tissue products and other.

The types of transplant in the market are autograft, allograft and allotransplantation, xenograft and xenotransplantation and other.

By type of treatment, the market is segmented into analgesic, immunosuppressant and other. Furthermore, immunosuppressant is sub-segmented into calcineurin inhibitors, mTOR inhibitor, antiproliferative agents, steroids and other. Calcineurin Inhibitors are further segmented into tacrolimus and cyclosporine, whereas mTOR inhibitor is sub-divided into sirolimus and everolimus.

The end users in the global organ transplantation market are hospitals, transplant centers and other.

Browse More Information @ 

Organ Transplantation Market Regional Insight

Region-wise, the market for organ transplantation is segmented into Europe, Asia Pacific, North America and the rest of the world (RoW).

According to the geographical distribution, America has risen to the top in the global organ transplantation market. The lucrative market growth in the region is the result of increasing prevalence of organ failure, well developed healthcare sectors, striking development in the medical sector, as well as strong healthcare expenditure.

Europe stands in the second position in the global organ transplantation market, followed by Asia Pacific. The Europe market benefits from the increasing research on stem cells to develop invitro tissue and organs coupled with the expanding healthcare infrastructure.

Asia Pacific has established itself as a strong contender, and is considered to be the fastest growing region in the global market. The presence of steadily developing nations, coupled with the large population pool afflicted with chronic diseases is working wonders for the regional market. Moreover, governments and various NGOs in the region are taking initiatives that are encouraging people to donate organs, thereby saving lives. To illustrate, in the year 2013, the government in Australia had conducted a national reform program for increasing organ donation as well as transplant. This move proved to be fruitful as there was an excellent growth in the number of organ donations compared to the previous year.

The organ transplantation market in the Middle East and Africa is steadily reaching a lucrative point in the global market, owing to ongoing investments in the existing models of organ donation, governmental legislations, and use of media and technology for increasing awareness.

Pharmacogenomics Market 2020 Covers Global Industry Share, Size, Future Trends, Demand, Business Insight by 2023

Pharmacogenomics is a relatively new field of study which is a combination of genomics and pharmacology. It studies how based on genes, a person reacts to drugs which aid in the development of more effective and safe medications. With Pharmacogenomics, drug doses can be tailored to a person’s genetic makeup and can be useful in the treatment of a wide range of health problems. The Global Pharmacogenomics Market Growth is likely to strike a CAGR of 5.8% over the forecast period of 2017-2023, predicts Market Research Future (MRFR) in an extensive study.

Chronic diseases are spreading at an alarming rate which has consequently boosted the demand for precision and personalized medicine. Pharmacogenomics has been widely recognized as a fundamental step in personalized medicine and growing demand for personalized medicine is propelling the growth of the global pharmacogenomics market.

The high rate of adverse drug reaction incidence has been linked to variations in genes which affect the efficacy and toxicity of drugs. This has evoked extensive R&D activities to find out the underlying causes for individual variable reaction to drugs. Pharmacogenomics can improve drug therapy and is increasingly being applied to drug discovery and development. Pharmaceutical companies are progressively making using of pharmacogenomics for drug safety improvisation to increase the success rate in pharmaceutical R&D activities. The governments in multiple countries are also encouraging pharmacogenomics to accelerate personalized care and are outlaying massive amounts on the same which is bolstering the growth of the global pharmacogenomics market.

On the other hand, the global pharmacogenomics market growth can be impeded by high costs associated with pharmacogenomics testing, the dearth of trained professionals to perform such tests and lack of proper laboratory infrastructure. Lack of standardization in procedures is also a possible bottleneck to the growth of the market.


The global pharmacogenomics market has been segmented based on technology, application, and end user.

By technology, the global pharmacogenomics market has been segmented into microarray, sequencing, polymerase chain reaction, and others. The sequencing segment has been further segmented into Sanger sequencing, pyrosequencing, next-generation sequencing, and others.

By application, the global pharmacogenomics market has been segmented into oncology, cardiology, neurological disorders, and others. The oncology segment has been further segmented into breast cancer, lung cancer, and others.

By end user, the global pharmacogenomics market has been segmented into hospitals, research organizations, academic institute, and others.

Competitive Landscape

Assurex Health, Inc. (U.S.), GeneTech (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), GeneDx. (U.S.), Future Science Group (U.S.), Pathway Genomics (U.S.), OneOme (U.S.), 23andMe, Inc. (U.S.), and Myriad Genetics, Inc. (U.S.) are the key players in the global pharmacogenomics market.

Browse More Information: 

Regional Analysis

By region, the global pharmacogenomics market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). The Americas dominate the global pharmacogenomics market and is likely to exhibit substantial growth over the forecast period. A robust healthcare sector, increasing number of patients suffering from cardiovascular diseases, and rising healthcare expenditure ease up the growth of the market. Presence of developed economies such as the US and Canada also augur well for the growth of the market.

Europe follows the Americas closely and is driven by the availability of funds for R&D along with government support for the same. Additionally, the presence of a massive patient population and developed economies such as Germany and France within the region fuels the growth of the market.

APAC is poised to be the fastest growing market for pharmacogenomics. Expanding pharmaceutical sector and outlay of substantial amount on R&D activities are factors supporting market growth. Presence of a vast patient base presents opportunities for the growth of the market.

MEA market accounts for the least share of the global pharmacogenomics market owing to poor economic conditions, low healthcare spending, and stringent government policies. The majority share of the MEA market is held by the Middle East where well-developed healthcare sector and huge healthcare expenditure supports the growth of the market.

Cardiac Pacemaker Market 2020 Global Growth Insights, Trends, Size, Share and Forecast to 2023

The global cardiac pacemaker market has been expanding with the rising burden of cardiac diseases and increasing need for cardiac rhythm management. Factors like atrial fibrillation and rising geriatric population is creating a robust growth scope for cardiac pacemaker market. By 2025 the global geriatric population is expected to surpass 2.1 billion. However, older people are more active now than they ever used to be and activities like swimming, jogging and riding bikes to stay fit are activities most people above the age of 50 indulge in and are recommended to pursue by doctors. However, disorders like cardiac arrhythmia can pose a significant hindrance to such activities and therefore more people are turning to cardiac implants like pacemakers to live a more active life. Assessments by Market Research Future affirms that cardiac pacemaker market is expecting a 7.9% CAGR over 2017-2023.

Cardiac Pacemaker Industry giants are also investing immensely in the development of enhanced pacemaker technologies to augment their position in the market. For instance, Medtronic created ripples in the cardiac pacemaker market when it launched the smallest pacemaker in the world. Micra, as the device is called was approved by the U.S. FDA in 2016 and is a part of Medtronic’s deep miniaturization program. It is a leadless pacemaker and is implanted directly into the patient’s heart and the minimally invasive surgery makes it possible to go back to daily activities within two days.

Competitive Insight:

There are several significant players in the cardiac pacemaker market such as Medtronic, BIOTRONIK, Boston Scientific Corporation, Abbott, MEDICO S.p.A., SORIN Group, LEPU MEDICAL, OSCOR Inc. etc. Most of these companies are investing heavily in research and development activities that can lend an added competitive edge to them. On the other hand, they are also undertaking strategic moves and investing in merger, acquisition and collaborations to gain an expanded share in the cardiac pacemaker market.


Cardiac pacemaker market is segmented on the basis of type, application, technology and end-users.

On the basis of type cardiac pacemaker market is further subdivided as external cardiac pacemaker, implantable and others.

By technology cardiac pacemaker market is classified into dual-chambered, single-chambered, biventricular and others.

Application-wise segmentation of cardiac pacemaker market comprises congestive heart failure, arrhythmias and others. Arrhythmias segment is further subdivided bradycardia, tachycardia and others.

End user segmentation of cardiac pacemaker market includes cardiac care centers, hospitals, medical institutes and others

Regional Analysis:

Geographically cardiac pacemaker market is subdivided into Americas, Europe, APAC and MEA. The Americas is expected to lead the cardiac pacemaker market due to the presence of better healthcare policies and superior infrastructure. Rising geriatric population has created a significant demand for cardiac pacemakers in the region. Lifestyle diseases that are leading to increased cardiac disorders and increased expenditure for better health are factors adding impetus to North America cardiac pacemaker market.

Browse More Information @ 

Europe cardiac pacemaker market is anticipated to account for the second largest revenue share due to increased government spending on enhancing the healthcare sector. Research and development activities seeking better and more efficient solution to cardiac disorders is expected to augment market growth in the region.

With emerging economies like China and India investing in healthcare infrastructure improvement, APAC region is slated to witness the fastest growing cardiac pacemaker market. Also, medical tourism in Asian countries has been on the rise which has led to increased infrastructure development for medical centers and in turn led to significant growth in the cardiac pacemaker market.

The MEA cardiac pacemaker market is expected to record slower growth due to lack of infrastructure and economic backwardness of the region.

Fertility Services Market 2020 – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2023

Rapid urbanization rates and changing lifestyles have affected fertility rates. But fertility services help in conceiving and offer a better alternative to surrogacy. According to a detailed Market Research Future report, the global fertility services market is expected to grow by almost 8.50% CAGR during the forecast period, 2018-2023.

The increase in the number of women in the labor market and their tendency towards higher education led to late family planning. This factor may contribute to market demand in the coming years. In addition, advancement in fertility treatment has given women the opportunity to have children later, which has increased market demand. The high costs of fertility treatments can be a challenge to market growth. However, reimbursement systems can have a positive impact on the market during the forecast period. Some of the factors that support the success of this segment are the prevalence of obesity, maternity age, endometrial tuberculosis, and other medical conditions. However, lack of awareness about the latest treatment procedure for infertility in developing countries and rural areas is predicted to hamper the growth of the global infertility services market.

Fertility Services Market Segmentation

Types of treatments include Assisted Reproductive Technology (ART) and infertility medications. The antiretroviral treatment segment is also segmented into artificial insemination, in vitro fertilization (IVF), frozen embryo replacement (FER), and others. The ART segment should be the preferred treatment for infertility due to the high success rate. In addition, the introduction of in vitro fertilization treatments, the availability of reimbursement systems that cover these options, and the patients’ disposable income may stimulate segment demand over the forecast period.

Major Players

The leading players supporting the growth of the global fertility services market comprise Irvine Scientific, Merck KGaA, Cook Medical, CooperSurgical Inc, Ferring Pharmaceuticals Inc., CARE Fertility Group Limited, and Vitrolife.

Regional Outlook

Europe has the largest market share of 34.6% due to the low fertility rate in this region. The tendency to delay family planning also contributes to market growth. The reimbursement policy in most European countries is also favorable to the demand for fertility services. Due to the convenience of advanced medical facilities and economic development, Western Europe is the most important market compared to Eastern Europe. The most important markets in this region are France, Italy, Germany, Spain, and the United Kingdom.

The Americas is the second-largest regional market, and North America accounts for most of the market revenue for the same reasons as in Europe. North America generates higher market revenues due to the presence of major market players, high obesity rates in the United States, and the subsequent decline in fertility rates. As a result, more women are turning to fertility services, leading to market growth. After the United States, Canada has the largest market share. A considerable portion of the market revenue also comes from Latin America.

Browse More Information:- 

The Asia Pacific region can grow at the fastest rate during the forecast period due to rapid urbanization, increasing fertility problems, and changing lifestyles. The use of advanced technologies and an increasingly favorable payment policy can foster fertility services market growth in countries such as India and Japan. Australia, China, and South Korea are other important markets in this region. An analysis of the other countries in the Asia-Pacific region presented in this report predicts the huge contribution to some other countries’ market revenues.

Market growth in the MEA region is low due to lack of awareness, limited availability of skilled health workers, various social constraints due to many religious and cultural factors, less investment in healthcare, and lack of advanced medical facilities.

Nurse Call System Market 2020 Global Market Trends, Share, Size, Growth, Opportunity and Forecast to 2023

Wireless Technologies to Revolutionize Global Nurse Call System Market: MRFR

Nurse call systems are a setup within a patient’s room for calling on nurses in case of emergencies. Some common features of these systems include wall station, desk console, bed cable, and pillow speaker. The Global Nurse Call System Market Trend report compiled by Market Research Future (MRFR) outlines the various drivers, opportunities, and challenges in a comprehensive gained by a combination of primary and secondary research.

Competition Outlook

Honeywell International Inc., CSINC, Systems Technologies, Jeron Electronic Systems Inc., West-Com Nurse Call System, Inc, AMETEK, Inc., Cornell Communications, Azure Healthcare, Hill-Rom Services Inc., Austco Communication Systems Pty Ltd., BEC Integrated Solutions, LLC, Ascom, STANLEY Healthcare, Vigil Health Solutions Inc., and Johnson Controls are prominent names in the global nurse call system market. Partnerships and agreements are major strategies incorporated by players in expanding their footprint globally. This is exemplified by the partnership between Ideacom Mid-America and Austco Marketing & Service (US) in 2018 for providing support and distribution of nurse call systems. Although product differentiation in minimal, the players aim to get the attention of their clients with novel designs and changes in application software.

Industry News

Caretel Inns, a U.S. senior assisted living center, has gained laurels for developing its own nurse call systems. The in-house smart assistant is in the form of a box and lets the residents voice their distress which would be answered immediately.

Market Overview

The global nurse call system market is anticipated to exhibit a CAGR of 9.5% during the forecast period (2018-2023). The large pool of geriatric patients who require assistance or patients in assisted living centers are two of the biggest drivers of the market. These systems can alert nurses in case of emergencies to provide immediate care and assistance. Expansion of hospital chains to cater to the large patient volume as well as to simplify their operations can spur the demand for nurse call systems.

The transition to mobile applications and the shift towards digitization by hospitals can positively influence the global nurse call system market. Considerable investments by governments for enhancing the existing hospital infrastructure as well as introduction of reimbursement schemes can bode well for the market. For instance, nearly 49 million elderly patients in the U.S. were covered by Medicare. The integration of these systems with wireless connections can disrupt the market growth positively.

High installation costs of these systems and stringent government policies can pose a challenge to the market growth.


The global nurse call system market is segmented by type, technology, application, and end-user.

By type, it is segmented into nurse call intercoms, nurse call buttons, nurse call mobile systems, nurse call integrated communication systems, and others.

By technology, it is segmented into wireless and wired systems.

Browse Complete Report @ 

By application, it is segmented into work flow management, medical emergency, alarms, and others.

By end-user, it is segmented into ambulatory care systems, assisted living centers, hospitals & nursing homes, and others. Hospitals & nursing homes are expected to continue their dominance in the global market due to the emergence of new hospitals in rural areas. In addition, upgradation of legacy infrastructure as well as new business plans by hospitals in increasing their revenue can bode well for the segment. On the other hand, the assisted living centers segment is projected to exhibit the fastest growth rate during the forecast period due to the expanding numbers of the geriatric populace being shifted to these centers.

Regional Analysis

The Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and North America are the main regions considered during the compilation of the market report.

The Americas are pegged to be the dominant region in the global nurse call system market due to the constant upgrades in technologies as well as the launch of new products. The large geriatric populace and the ballooned healthcare funding provided for well-being of patients by developed economies of Canada and the U.S. can augur well for the region.

Europe is deemed to contribute a sizeable amount to the global market revenue earnings due to the large patient pool and a well-developed healthcare sector. On the other hand, APAC is expected to exhibit a robust growth rate due to the developed healthcare infrastructure of economies and the large aged populace.

Blood Transfusion Diagnostics Market 2020 – Investment Strategy, Outlook and Key Development till 2023

Blood transfusion is a process that ensures safe intravenous transfer of blood or blood products. The process can also allow replacement of blood. Various blood components like red blood cells, white blood cells, platelets, clotting factors and plasma can also be transfused. These components find great application in hospitals during emergencies. The Global Blood Transfusion Diagnostics Market Size has been predicted to grow up to USD 2.45 billion in 2023 with a CAGR of 8.2% over the review period of 2017-2023. Market Research Future (MRFR) claims that the global market has the potential to surpass market predictions and ensure better growth for itself.

Various factors, like technological advancements, safe transfer procedures, various chronic diseases, and others can impact the global market. But the process requires proper screening to prohibit any unwanted disease to get transferred. Governments have introduced stringent measures to prohibit such cases from having. Hike in the campaign to promote the process can also be suggested as a good market backup.

Blood Transfusion Diagnostics Market Competitive Landscape:

Prominent companies taking part in the global blood transfusion diagnostics market are Roche Diagnostics (Switzerland), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Immucor (U.S),  bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Beckman Coulter (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S Abbott Diagnostics (U.S),), Biokit (Spain). MRFR profiled these companies to have their market analyzed in a better way.

Blood Transfusion Diagnostics Market Segmentation:

The global blood transfusion diagnostics market report has been segmented by MRFR for a better understanding of the factors that can impact the market in the coming years. This segmentation has better insights to provide a better direction for the coming years.

Based on the blood product, the global blood transfusion diagnostics market can be segmented into red blood cells, platelets, plasma, albumin, immunoglobulin preparations and other products.

Based on the technology, the blood transfusion diagnostics market comprises western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test and other technologies. The ELISA segment comprises fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The Nucleic Acid Amplification segment includes Thermomechanical analysis (TMA) and real-time PCR.

Based on the end-users, the blood transfusion diagnostics market can be segmented into hospitals, clinics, blood banks, and laboratories. The hospitals segment has substantial market coverage as a lot of people opt for this option to undergo the process.

Browse More Information @ 

Blood Transfusion Diagnostics Market Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions that have been included in the geographical reading of the global blood transfusion diagnostics market. The process eases the identification steps for the growth pockets.

The Americas is known for their high impact on the global blood transfusion diagnostics market. Several factors are working in favor of the growth of the regional blood transfusion diagnostics market, among them increasing adoption of nucleic acid implication test of diagnosis, automation of blood banks and stringent rules for storage & transfusion of blood play integral roles. The growth is exceptionally well in North America where the presence of the U.S. and Canada are playing important roles.

Europe’s growth has base in features that are quite similar to that of the Americas. The market is witnessing substantial hike in the demand for improved diagnostics test, availability of the skilled healthcare professionals and better collaboration with NGO’s, which can be accredited for the growth of the regional market. The APAC market is all set to get the highest growth during the forecast period where Japan would posit itself as the largest market. The market is also expecting strong traction from countries like China and India. These two countries are showing substantial integration of the latest technologies that can impact the regional market and influence their individual outcome.

Injection Pen Market 2020: Key companies Profile, their market Share and Growth Insights to 2023

Healthcare sector is already underway towards revolution with competition amid key players getting intense and growing aggression to develop devices that sync well with latest connected devices. Similarly, injection pen is one of the crucial innovations in the field of drug delivery. Market Research Future estimated that the Global Injection Pen Market Growth would attain a CAGR of 6.5% during the forecast period 2017-2023.

Manufacturers recognizing the importance of advanced drug delivery devices, increased investment in digital and healthcare analytics are some of the modern trends that might spur the growth of the global injection pen market. Consumers inclination on personalized and smart products has led to increased demand insights for injection pens. Rapid scaling and sophisticated service offering by the service providers have also helped to uphold the growth of the global market. Moreover, growing prevalence of chronic diseases such as osteoporosis and diabetes are anticipated to drive the global injection pen market. Changing lifestyle, unhygienic food consumption, and a growing number of patients who require daily dose of insulin are some of the factors that are of root disease outbreak, leading to increased numbers in patients.

Big technology players and venture capitalists are bringing high-tech product architectures that are creating lucrative opportunities for the healthcare industries.

Competitive players

Industry leaders are rapidly shifting from the beta test and experiments to full-fledged product building. These leading giants include the Novo Nordisk, Ypsomed, Sanofi, Owen Mumford, F. Hoffman-La Roche, Jiangsu Delfu Medical Device Co. Ltd., Pfizer, Becton Dickinson and Company, Biocon Ltd., Haselmeier, Merck, AstraZeneca, Eli Lilly, and Novartis.

Industrial updates

 Biocorp, healthcare connected device maker has launched a cap for pen injectors that is internet-connected and transmit dosage information to a mobile app. The company stated that it is in talks with Sanofi’s diabetes care platform for negotiations. Its smart sensor cap, named Mallya is the only connected device with injections pens that is accessed to attain the accuracy requirements to achieve CE Class IIb classification by EU regulators. Earlier, in 2016, Companion Medical based in San-Deigo got FDA clearance for the wireless-enabled smart insulin pen, named Inpen 


The rise in R&D activities in drug delivery is anticipated to play a major role in uplifting the growth graph of the global injection pen market during the forecast period.

The global injection pen market is broadly classified based on factors such as type, product, therapy, and end-user.

Based on type, the global injection pen market is bifurcated into disposable injection pens and reusable injection pens.

By product, the global market is segmented into pen needles and insulin pens.

Moreover, the global injection pen market is also segmented based on various therapies such as diabetes, fertility, growth hormone therapy, and osteoporosis.

The end-user segment is classified as home care, hospital, and clinics.

Browse More Information:- 

Regional Analysis

The Americas dominate the global injection pen market and are expected to maintain its influence during the forecast period. The leading position of the region in the global market is attributed to high adoption rate of injection pens and growing awareness of the drug delivery devices. Existence of leading market giants in Canada and the U.S. is encouraging the growth of the pen injection market in the region.

Following the Americas, Europe has a leading role in the global market, owing to burgeoning diabetics. Growing cases of diabetes have forced manufacturers to develop effective and convenient ways to handle the disease, as diabetes requires day-to-day administration of insulin injections. Thus, feasibility of self-managing the disease has boosted the demand for injection pen in region.

Moreover, the Asia Pacific is an emerging region with immensely growing population; the ratio of patient population with chronic is high. Rise in the figures of diabetics and increased healthcare expenditure has stimulated the growth of the global injection pen market.

The Middle East has the lowest share in the global injection pen market; however, upcoming healthcare investments led by some industrial players is expected to spur the growth rate of the regions.

Medical Bionic Implant/Artificial Organs Market 2020 Global Overview, Regional Analysis, Size, Share and Forecast to 2023

Bionic implants are known for being artificially engineered devices that can be implanted inside a human to assist or replace a natural organ. The technology has gained traction as a life support to prevent immediate death and improve patient’s condition. The global Medical Bionic Implant/Artificial Organs Market Growth is looking forward for market situations where it can achieve 7% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) in their detailed report talked about several factors that can influence the global market growth.

Factors like increasing accidents & injuries, increasing government assistance, improving regulatory framework, technological advancements, and others can inspire growth for the global medical bionic implant/artificial organs market.

However, lack of skilled professionals, costly devices, and poor healthcare system in developing countries can detract the market from the market to an extent.

Competitive Landscape:

Several companies are making their grounds strong in the global medical bionic implant/artificial organs market by implementing various strategies. These strategies include merger, acquisition, innovation, branding, marketing, and others. MRFR enlisted several companies in the report to understand the market flow. These companies are Biocontrol Medical (Israel), Aleva Neurotherapeutics SA (Switzerland), Boston Scientific Corporation (U.S.), Biomet, Inc. (U.S.), Cyberonics, Inc. (U.S.), Cochlear Ltd. (Australia), LivaNova PLC (U.K), Ekso Bionics (U.S.), NeuroPace, Inc. (U.S.), Medtronic, Inc. (U.S.), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Orthofix International N.V. (The Netherlands), and St. Jude Medical, Inc. (U.S.).

In September 2019, researchers from the Harvard University announced the launching of a new method to print human organs on a 3D printer. The technique is called SWIFT or sacrificial writing into functional tissue.


The global medical bionic implant/artificial organs market has been segmented for the report published by MRFR that can facilitate better understanding of the market. These segments are technology, product, fixation, and end-user. These segments hold details of various factors that can impact the market in the coming years.

Based on the technology, the medical bionic implant/artificial organs market can be segmented into mechanical bionics and electronic bionics.

By product, the medical bionic implant/artificial organs market includes vision bionics, heart bionics, neural/brain bionics, ear bionics, orthopedic bionics, and others. Vision bionics segment includes bionic eye and others. Ear bionics segment encompasses cochlear implant and Bone Anchored Hearing Aid (BAHA). Orthopedic bionics segment covers bionic finger, bionic hand, bionic leg, exoskeleton, and electrical bone growth stimulators. The sub-segments of bionic leg can be segmented into bionic knee and bionic feet. The sub-segments of electrical bone growth stimulators reveal invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics segment includes pacemaker, ventricular assist device, total artificial heart, and artificial heart valve. The sub-segments of pacemaker cover implantable cardiac pacemaker and external pacemaker. The segmentation of artificial heart valve includes mechanical heart valve and tissue heart valve. Neural/brain bionics centers around vagus nerve stimulator, deep brain stimulators, and spinal cord stimulators.

Browse More Information:- 

Based on the fixation, the medical bionic implant/artificial organs market encompasses implantable and externally worn.

By end-user, the medical bionic implant/artificial organs market has better understanding of hospitals & clinics, research & academic institutes, and others.

Regional Analysis:

The region-specific study of the global medical bionic implant/artificial organs market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). Such an analysis has better understanding of various demographic challenges and dynamics, which can ensure better market understanding. 

The Americas has the better the medical bionic implant/artificial organs market stance and it depends mostly on the performance of North America. The US, Canada, and others are expected to gain substantially in the coming years due to their robust infrastructure and superlative market condition. Europe is following similar footsteps owing to which the regional presence is becoming stronger. The APAC market is benefiting from several countries taking initiatives to revamp their market infrastructure. The regional market is banking on countries like China, India, and others for definite growth.

Dental 3D Printing Market 2020 Global Growth Insights, Trends, Size, Share and Forecast to 2023

The global dental 3D printing market is expected to exhibit a robust 24.5% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a detailed analysis of the global dental 3D printing market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global dental 3D printing market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global Dental 3D Printing Market Size are also studied in the report and projections are made for the growth trajectory of each distinct component. The various segments and sub-segments within the global dental 3D printing market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global dental 3D printing market and provides a detailed look at the various competitive strategies employed by players in the global dental 3D printing market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

The growing dental healthcare sector is likely to be the major driver for the global dental 3D printing market. Due to the growing prevalence of dental caries and other dental conditions, the dental healthcare sector has grown at a rapid pace over the last few years. The increasing demand for innovative solutions in the dental healthcare sector has also driven the demand for dental 3D printing. Dental 3D printing can be used to print out crowns, bridges, dentures, and other dental implements at low costs and effort. This has driven the adoption of 3D printing in the dental healthcare sector. The increasing complexity and sophistication of 3D printing technology is also responsible for the growing adoption of 3D printing in dental healthcare, as increasingly complicated structures can be easily printed out via 3D printing, reducing the efforts required of dentists and dental technicians. Increasing demand for precise fitting in dental implements is likely to result in an increasing demand from the dental 3D printing market over the forecast period.

Competitive Analysis:

Leading players in the global dental 3D printing market include Roland DG, Asiga, Rapid Shape GmbH, EOS GmbH Electro Optical Systems, Concept Laser GmbH, Carbon Inc., SLM Solutions Group, Prodways Group, Formlabs, Renishaw plc, DWS Systems, EnvisionTEC Inc., 3D Systems Inc., and Stratasys Ltd.

In November 2019, Formlabs announced a new wing called Formlabs Dental, dedicated to 3D printing of dental healthcare equipment and implements.


The global dental 3D printing market has been segmented on the basis of product and service, technology, application, end user, and region.

On the basis of product and service, the global dental 3D printing market has been segmented into equipment, materials, and services. The equipment segment has been sub-segmented into dental 3D scanners and dental 3D printers. The materials segment has been sub-segmented into plastic, metal, and other materials.

On the basis of technology, the dental 3D printing market has been segmented into vat photopolymerization, fused deposition modelling (FDM), polyjet technology, selective laser sintering, and other technologies. The vat photopolymerization segment has been further sub-segmented into stereolithography and digital light processing.

Browse More Information: 

The market, by application, has been segmented into prosthodontics, orthodontics, and implantology.

On the basis of end user, the dental 3D printing market has been segmented into dental laboratories, dental hospitals and clinics, dental academic and research institutes.

Regional Analysis:

The Americas holds the dominant share in the global dental 3D printing market, followed by Europe. The strong presence of leading players in 3D printing technology in North America and Europe is the major driver for the dental 3D printing market in these two regions.

Create your website at
Get started